Tradestie Institutional Equity Comparison Engine

DSGN vs IMCR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DSGN Overall Edge

DSGN Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Design Therapeutics, Inc. Common Stock (DSGN) driven by superior Growth & Margin, Momentum & Technical while IMCR counters with relative strength in Valuation, Options & Structure. Fundamentally, DSGN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IMCR at 23.8x Forward P/E and -2.2% operating margin (-1.4% YoY). In options structure, DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro) against IMCR sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IMCR
DSGN N/M vs IMCR 23.8x Fwd P/E
Growth & Margin Winner DSGN
Op Margin 0.0% vs -2.2% ยท YoY +0.0% vs -1.4%
Momentum & Technical Winner DSGN
1Y +40.8% vs -17.7% ยท 52W Pos 30% vs 12%
Options & Structure Winner IMCR
BREAKDOWN (13th %ile IV) vs UNCLASSIFIED (10th %ile IV)
DSGN NASDAQ
Design Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.94
-5.06% 1D
Market Cap $677.5M
1M Return -3.59%
1Y Return +40.79%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 63.0 Mom 54.0
IMCR NASDAQ
Immunocore Holdings plc American Depositary Shares
Biological Products, (No Disgnostic Substances)
$29.10
-2.81% 1D
Market Cap $1.6B
1M Return -1.02%
1Y Return -17.73%
Forward P/E 23.8x
Unified AI Score
46.5 / 100 HOLD
Tech 47.0 Fund 50.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DSGN +40.79% IMCR -17.73% Spread: +58.52 pp (DSGN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DSGN TTM Op. Margin: 0.0% IMCR TTM Op. Margin: -2.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DSGN vs IMCR. Trailing 12-month operating profitability (DSGN 0.0% vs IMCR -2.2%) and valuation multiples (DSGN N/M vs IMCR 23.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DSGN (5) vs IMCR (5)
Institutional Metric DSGN IMCR Criterion Row Winner
Market Capitalization Scale $677.5M $1.6B Larger Scale IMCR
Trailing P/E Ratio Valuation N/M 23.8x Lower Multiple IMCR
Forward P/E Ratio Valuation N/M 23.8x Lower Multiple IMCR
Revenue Growth (YoY) Growth +0.0% -1.4% Higher Growth DSGN
Operating Margin (TTM) Profitability 0.0% -2.2% Higher Margin DSGN
Net Profit Margin Profitability 0.0% -7.5% Higher Margin DSGN
Return on Equity (ROE) Capital Efficiency -36.9% -7.9% Higher ROE IMCR
52-Week Range Position Momentum 30% ($7โ€“$17) 12% ($28โ€“$41) Stronger Trend DSGN
Beta / 30D Volatility Risk Regime 1.32ฮฒ ยท 61% Vol 0.63ฮฒ ยท 59% Vol Lower Realized Risk IMCR
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 46.5 / 100 (HOLD) Higher Composite DSGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DSGN vs IMCR Buy Guide
DSGN BREAKDOWN
139d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live DSGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IMCR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live IMCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DSGN nor IMCR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.